Expression and modulation of connexin 30.2, a novel gap junction protein in the mouse retina.
Mammalian retinae express multiple connexins that mediate the metabolic and electrical coupling of various cell types. In retinal neurons, only connexin 36, connexin 45, connexin 50, and connexin 57 have been described so far. Here, we present an analysis of a novel retinal connexin, connexin 30.2 (Cx30.2), and its regulation in the mouse retina. To analyze the expression of Cx30.2, we used a transgenic mouse line in which the coding region of Cx30.2 was replaced by lacZ reporter DNA. We detected the lacZ signal in the nuclei of neurons located in the inner nuclear layer and the ganglion cell layer (GCL). In this study, we focused on the GCL and characterized the morphology of the Cx30.2-expressing cells. Using immunocytochemistry and intracellular dye injections, we found six different types of Cx30.2-expressing ganglion cells: one type of ON-OFF, three types of OFF, and two types of ON ganglion cells; among the latter was the RG A1 type. We show that RG A1 cells were heterologously coupled to numerous displaced amacrine cells. Our results suggest that these gap junction channels may be heterotypic, involving Cx30.2 and a connexin yet unidentified in the mouse retina. Gap junction coupling can be modulated by protein kinases, a process that plays a major role in retinal adaptation. Therefore, we studied the protein kinase-induced modulation of coupling between RG A1 and displaced amacrine cells. Our data provide evidence that coupling of RG A1 cells to displaced amacrine cells is mediated by Cx30.2 and that the extent of this coupling is modulated by protein kinase C.
Müller
Luis Pérez de Sevilla
LP
Department of Neurobiology, University of Oldenburg, Oldenburg, Germany.
Dedek
Karin
K
Janssen-Bienhold
Ulrike
U
Meyer
Arndt
A
Kreuzberg
Maria M
MM
Lorenz
Susanne
S
Willecke
Klaus
K
Weiler
Reto
R
D000165:Acridine Orange / Q000378:metabolism; D025042:Amacrine Cells / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives / Q000378:metabolism; D017630:Connexins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D007381:Intermediate Filament Proteins / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009419:Nerve Tissue Proteins / Q000235:genetics; D064231:Nestin; D010648:Phenylacetates / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism; D012160:Retina / Q000166:cytology* / Q000378:metabolism*; D012165:Retinal Ganglion Cells / Q000187:drug effects / Q000378:metabolism; D019311:Staurosporine / Q000494:pharmacology
D017630:Connexins; D004791:Enzyme Inhibitors; D007381:Intermediate Filament Proteins; D009419:Nerve Tissue Proteins; C577485:Nes protein, mouse; D064231:Nestin; D010648:Phenylacetates; C510757:connexin 30.2, mouse; C070614:neurobiotin; C012776:biphenylylacetic acid; D001710:Biotin; D011493:Protein Kinase C; D000165:Acridine Orange; D019311:Staurosporine